Cross-kingdom botanical intelligence platform. Predicts therapeutic compounds across four biological kingdoms — cannabis, marine polysaccharides, fungi, and plant polysaccharides — before physical testing.
NeuroBotanica™ combines a patented workflow integration methodology with proprietary analytical engines to deliver pharmaceutical-grade therapeutic prediction at accessible price points.
The platform's proprietary AI prediction model predicts molecular interactions across compound classes. The dimeric prediction framework generates 21,000+ novel molecular combinations with formation probability, synergy scores, and condition-specific therapeutic potential.
Cannabis is the entry point — not the ceiling. The dispensary pilot and budtender application are the first commercial vertical in a 7-phase expansion reaching pharmaceutical R&D, clinical medicine, and cultivation.
Our proprietary AI prediction model predicts cross-kingdom molecular interactions. Not a lookup table — a generative model.
Web-based application for Nevada dispensary staff. Evidence-based product recommendations backed by 565+ peer-reviewed studies. Replaces guesswork with science.
Polysaccharide-cannabinoid receptor interaction modeling. Marine, fungal, and plant polysaccharides mapped against cannabinoid and terpene classes.
Every recommendation ranked by evidence quality. Meta-analysis → RCT → cohort → in vitro → traditional use. Fully auditable at every step.
The traditional knowledge integration layer integrates FPIC-validated traditional knowledge. VeriTrad™-verified, consent-logged, attribution-tracked.
The regulatory pathway mapping layer maps compounds to FDA and DSHEA pathways. GRAS notifications, NDI submissions, clinical trial readiness built in.
The Nevada pilot entry point. Web-based recommendation system. Evidence-based guidance for dispensary staff and patients.
Join Nevada PilotAccess to 565+ study database, proprietary AI predictions, and cross-kingdom synergy models. API access for academic and industry researchers.
Request AccessClinical protocols, patient digital twins, neuropsychiatric therapeutics. Clinical and neuropsychiatric protocols. 3,000+ target US facilities.
Learn MoreRecruiting Nevada dispensaries for the Aug 2026 pilot launch. Free onboarding. Web-based deployment. Full training included.